American Tungsten Corp. Announces Completion of Name Change

(CNSX:TUNG),(OTC US:DEMRF),(OTCQB:DEMRF),(Boerse Frankfurt – Freiverkehr:RK9),(OTC US:DEMRF),(Other OTC:DEMRF), Vancouver, BC, Jan. 23, 2025 (GLOBE NEWSWIRE) — American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company“) is pleased to announce, further to its news release dated January 20, 2025, that it has formally completed its name change and rebranding from Demesne Resources Inc. This transformation […]

Stardust Power Breaks Ground on One of The Largest U.S. Battery-Grade Lithium Refineries

(NasdaqGM:SDST),(NasdaqGM:SDSTW), Lieutenant Governor, Matt Pinnell and Roshan Pujari, Founder and CEO, Stardust Power break ground at the Stardust Power ceremony, January 22nd, 2025 GREENWICH, Conn., Jan. 23, 2025 (GLOBE NEWSWIRE) — Stardust Power Inc. (the “Company” or “Stardust Power”) (NASDAQ: SDST), an American developer of battery-grade lithium products, officially broke ground on January 22, 2025,

Axalta Appoints Tim Bowes as President, Global Industrial Coatings

(NYSE:AXTA), PHILADELPHIA, Jan. 23, 2025 (GLOBE NEWSWIRE) — Axalta Coating Systems Ltd. (NYSE: AXTA) (“Axalta” or the “Company”), a leading global coatings company, today announced that Tim Bowes has been appointed President, Global Industrial Coatings, effective January 27, 2025. Mr. Bowes will succeed Shelley Bausch who will be stepping down from her role. Most recently,

Belo Sun Mining Announces Permitting Update on the Volta Grande Gold Project in Brazil

(TSX:BSX),(OTC US:BSXGF),(Other OTC:BSXGF), TORONTO, Jan. 23, 2025 (GLOBE NEWSWIRE) — Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX:BSX, OTCQB:BSXGF) reports that the Federal Court of Appeals in Brasilia (TRF1) has unanimously ruled that the Secretariat of Environment and Sustainability of the State of Para (SEMAS) will be the competent authority for the environmental

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

(NasdaqGM:IXHL), Demonstrated bioavailability of IHL-42X, Incannex's proprietary combination formulation, confirming delivery of both dronabinol and acetazolamide Achieved similar PK and equivalent total drug exposure levels of IHL-42X and the reference listed drugs (RLD) for dronabinol and acetazolamide, building a scientific bridge to established safety and toxicology data with the potential to support a future FDA

Red Cat Secures $518K in New Orders for Edge 130 Drones from U.S. Government Agencies

(NASDAQ:RCAT), SAN JUAN, Puerto Rico, Jan. 23, 2025 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, today announced it has secured new orders for its Edge 130 drone from the Army National Guard and

Attovia Therapeutics Announces First Participant Dosed in First-in-Human Phase 1 Study of ATTO-1310, its Novel Half-life Extended Anti-IL-31 ATTOBODY for the Treatment of Chronic Pruritus

ATTO-1310 offers a potential treatment for pruritic indications like CPUO where no approved treatments exist, and the potential for best-in-disease efficacy across pruritic conditions First drug candidate to enter the clinic that utilizes the company's proprietary ATTOBODY platform, which offers best-in-class potency and unconstrained engineering potential FREMONT, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) — Attovia

InflaRx Announces Participation in Guggenheim SMID Cap Biotech Conference

(NASDAQ:IFRX), JENA, Germany, Jan. 23, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it will participate in the Guggenheim SMID Cap Biotech Conference, to be held February 5 – 6, 2025 in New York, NY. About InflaRx InflaRx (Nasdaq: IFRX) is

Stock Yards Bancorp to Participate in the Janney Annual CEO Forum

(NASDAQ:SYBT), LOUISVILLE, Ky., Jan. 23, 2025 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that Ja Hillebrand, Chairman and CEO, and T. Clay

Neumora Therapeutics, Inc. (NMRA) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

NEW YORK, NY / ACCESSWIRE / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neumora Therapeutics, Inc. ("Neumora Therapeutics, Inc.") (NASDAQ:NMRA) concerning possible violations of federal securities laws. On January 2, 2025, Neumora announced its experimental depression treatment failed in the first of three studies planned by

Scroll to Top